VR17-04

• Bioactivity :

  VR17-04, a metabolite of Enisamium, inhibits the incorporation of GTP and UTP during RNA synthesis. Its mechanism of action was elucidated through docking and molecular dynamics simulations. These findings suggest that VR17-04 could serve as a potential antiviral strategy for managing COVID-19.

• Smiles :

  O=C(NCC=1C=CC=CC1)C2=CC=[N+](C=C2O)C

• Molecular Formula :

  C14H15N2O2

• Molecular Weight :

  243.28

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2417925-64-3